Zhengkun Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhengkun Chen has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Eugenia Kumacheva
Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada
5 shared publications - Sofia M. Morozova
Moscow Center for Advanced Studies, Kulakova Str. 20, 123592 Moscow, Russia
3 shared publications - Chunyi Wen
Department of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China
2 shared publications Dianoosh Kalhori
The Institute of Biomedical Engineering University of Toronto Toronto Ontario Canada
2 shared publications- Ilya Yakavets
Department of Chemistry, University of Toronto, 80 Saint George Street, Toronto, ON M5S 3H6, Canada
2 shared publications Liangliang Qu
BASF Advanced Formulation Research North America, 500 White Plains Road, Tarrytown, New York, 10591, USA
2 shared publications
Latest Publications
- Open Access
- 29 April 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (48) , e75639
Active Learning‐Accelerated Discovery of Fibrous Hydrogels with Tissue‐Mimetic Viscoelasticity
The extracellular matrix (ECM) exhibits tissue‐specific viscoelasticity with a unique combination of elasticity and viscosity. Hydrogels with independently controlled elastic modulus and stress relaxation have been developed. Yet, time‐ and labor‐efficient identification of formulations used for the preparation of multicomponent hydrogels recapitulating the mechanical properties of a specific tissue remains a challenge. Conventional bottom‐up screening of hydrogel formulations is resource‐intensive, especially for navigating multicomponent hydrogels. Here, we present an active learning framework based on multi‐objective Bayesian optimization to accelerate the discovery of biomimetic fibrous hydrogels replicating the elastic and viscous properties of the ECM of healthy and diseased tissues. In the data‐driven approach, we iteratively navigated the multidimensional chemical space, while simultaneously optimizing hydrogel's conflicting mechanical properties and mapping the boundaries of material feasibility using sparse experimental feedback. The experimental data were used to train a digital twin model and unveil the interplay between the fabrication conditions and hydrogel properties. The decoupled effects of the elasticity and viscosity were established for cell activation, proliferation, and morphogenesis. This work shows the potential of using the data‐driven approach, leveraging even sparse experimental data to engineer hydrogels and optimize diverse biomaterials for tissue engineering and regenerative medicine.
- 29 April 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (48) , e75639
Open AccessActive Learning‐Accelerated Discovery of Fibrous Hydrogels with Tissue‐Mimetic Viscoelasticity
The extracellular matrix (ECM) exhibits tissue‐specific viscoelasticity with a unique combination of elasticity and viscosity. Hydrogels with independently controlled elastic modulus and stress relaxation have been developed. Yet, time‐ and labor‐efficient identification of formulations used for the preparation of multicomponent hydrogels recapitulating the mechanical properties of a specific tissue remains a challenge. Conventional bottom‐up screening of hydrogel formulations is resource‐intensive, especially for navigating multicomponent hydrogels. Here, we present an active learning framework based on multi‐objective Bayesian optimization to accelerate the discovery of biomimetic fibrous hydrogels replicating the elastic and viscous properties of the ECM of healthy and diseased tissues. In the data‐driven approach, we iteratively navigated the multidimensional chemical space, while simultaneously optimizing hydrogel's conflicting mechanical properties and mapping the boundaries of material feasibility using sparse experimental feedback. The experimental data were used to train a digital twin model and unveil the interplay between the fabrication conditions and hydrogel properties. The decoupled effects of the elasticity and viscosity were established for cell activation, proliferation, and morphogenesis. This work shows the potential of using the data‐driven approach, leveraging even sparse experimental data to engineer hydrogels and optimize diverse biomaterials for tissue engineering and regenerative medicine.
- 26 June 2025
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 25 (16) , 4038-4047
Spheroid-based skin-on-a-chip platform for the evaluation of the toxicity of small molecules and nanoparticles
Exposure of human skin to chemical agents may lead to skin sensitization, irritation, and corrosion. Time-efficient toxicity screening is currently achieved using in vitro skin-on-a-chip models; however, these either lack a multilayer structure characteristic of the skin, or require long fabrication time. Here, we report the development and proof-of-concept application of the microfluidic spheroid-based skin-on-a-chip platform utilizing gravity-driven flow and large arrays of multilayer skin spheroids (MSSs). The MSSs containing human dermal fibroblasts in the core and keratinocytes in the shell replicated the dermal and epidermal layers of skin, respectively. Within 3 days, the toxicity of five distinct small molecules was characterized by measuring their IC50 values, which enabled the differentiation of non-irritant chemical agents from the irritant ones and correlated with their in vivo scores for skin irritation. Toxicity screening was extended to nanoparticles, including carbon dots, liposomes, and insecticide-loaded liposomes. This MSS-based skin-on-a-chip microfluidic platform for the safety evaluation of small molecules and nanoparticles has diverse applications in the skincare, pharmaceutical, and agriculture fields.
- 26 June 2025
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 25 (16) , 4038-4047
Spheroid-based skin-on-a-chip platform for the evaluation of the toxicity of small molecules and nanoparticles
Exposure of human skin to chemical agents may lead to skin sensitization, irritation, and corrosion. Time-efficient toxicity screening is currently achieved using in vitro skin-on-a-chip models; however, these either lack a multilayer structure characteristic of the skin, or require long fabrication time. Here, we report the development and proof-of-concept application of the microfluidic spheroid-based skin-on-a-chip platform utilizing gravity-driven flow and large arrays of multilayer skin spheroids (MSSs). The MSSs containing human dermal fibroblasts in the core and keratinocytes in the shell replicated the dermal and epidermal layers of skin, respectively. Within 3 days, the toxicity of five distinct small molecules was characterized by measuring their IC50 values, which enabled the differentiation of non-irritant chemical agents from the irritant ones and correlated with their in vivo scores for skin irritation. Toxicity screening was extended to nanoparticles, including carbon dots, liposomes, and insecticide-loaded liposomes. This MSS-based skin-on-a-chip microfluidic platform for the safety evaluation of small molecules and nanoparticles has diverse applications in the skincare, pharmaceutical, and agriculture fields.
- Open Access
- 9 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (19) , eadu1251
Hydrodynamically generated multilayer skin spheroids enable in vitro screening of biologically active ingredients and toxicity tests
Human tissues often have a multilayer structure, with each layer performing a distinct physiological task. Reconstructing layered tissue structures with their respective functions is crucial for disease modeling, screening biologically active ingredients, and performing toxicology tests; however, multicellular spheroids used for these purposes generally lack a well-defined multilayer architecture. Here, to recapitulate a multilayer structure of the skin, we developed a hydrodynamically mediated approach to the generation of large arrays of fibroblast spheroids (a dermal core) that were engulfed with an epidermal layer of keratinocytes. These spheroids expressed biomarkers of the epidermis, epidermal-dermal junction, and dermis, and exhibited skin-like barrier properties. Screening of the synergistic effect of vitamins and peptides on protein synthesis by the spheroids and evaluation of skin toxicity with chemical agents showed a correlation with clinical results or existing standards. This approach offers enhanced control over spatial cell distribution in spheroids for advanced in vitro models of multilayer tissues.
- 9 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (19) , eadu1251
Open AccessHydrodynamically generated multilayer skin spheroids enable in vitro screening of biologically active ingredients and toxicity tests
Human tissues often have a multilayer structure, with each layer performing a distinct physiological task. Reconstructing layered tissue structures with their respective functions is crucial for disease modeling, screening biologically active ingredients, and performing toxicology tests; however, multicellular spheroids used for these purposes generally lack a well-defined multilayer architecture. Here, to recapitulate a multilayer structure of the skin, we developed a hydrodynamically mediated approach to the generation of large arrays of fibroblast spheroids (a dermal core) that were engulfed with an epidermal layer of keratinocytes. These spheroids expressed biomarkers of the epidermis, epidermal-dermal junction, and dermis, and exhibited skin-like barrier properties. Screening of the synergistic effect of vitamins and peptides on protein synthesis by the spheroids and evaluation of skin toxicity with chemical agents showed a correlation with clinical results or existing standards. This approach offers enhanced control over spatial cell distribution in spheroids for advanced in vitro models of multilayer tissues.
- 10 October 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (3)
Phytoglycogen Nanolubricants with Extended Retention Time in Joints
Osteoarthritis is a prevalent chronic health condition that is mostly associated with the degeneration of joint cartilage due to aging or abnormal mechanical stress in the joint. Intraarticularly injected nanoparticle‐based lubricants decrease the friction between damaged cartilage surfaces, thus preventing their further degradation; however, the effectiveness of currently used nanoparticle‐based lubricants is limited by their short retention time in the joint space. To address this challenge, cationically modified biosourced phytoglycogen nanolubricants are utilized, which electrostatically bind to the cartilage components. The conjugation of the nanoparticles with red‐emissive fluorescent carbon dots enables in vivo studies of their retention in the joint. The hytoglycogen nanoconjugates exhibit high colloidal stability in physiological conditions, provide a friction coefficient of 10−3–10−2 between the sliding surfaces under physiologically relevant pressures, strongly bind to the major cartilage surface components, and show significantly prolonged retention time in the joint in vivo, with a fourfold increase in half‐life in comparison with conventionally used hyaluronic acid injectant. These properties make these functionalized phytoglycogen nanoparticles a highly promising candidate for joint lubrication.
- 10 October 2024
- Published by Wiley in Advanced Functional Materials
- Vol. 35 (3)
Phytoglycogen Nanolubricants with Extended Retention Time in Joints
Osteoarthritis is a prevalent chronic health condition that is mostly associated with the degeneration of joint cartilage due to aging or abnormal mechanical stress in the joint. Intraarticularly injected nanoparticle‐based lubricants decrease the friction between damaged cartilage surfaces, thus preventing their further degradation; however, the effectiveness of currently used nanoparticle‐based lubricants is limited by their short retention time in the joint space. To address this challenge, cationically modified biosourced phytoglycogen nanolubricants are utilized, which electrostatically bind to the cartilage components. The conjugation of the nanoparticles with red‐emissive fluorescent carbon dots enables in vivo studies of their retention in the joint. The hytoglycogen nanoconjugates exhibit high colloidal stability in physiological conditions, provide a friction coefficient of 10−3–10−2 between the sliding surfaces under physiologically relevant pressures, strongly bind to the major cartilage surface components, and show significantly prolonged retention time in the joint in vivo, with a fourfold increase in half‐life in comparison with conventionally used hyaluronic acid injectant. These properties make these functionalized phytoglycogen nanoparticles a highly promising candidate for joint lubrication.
- Open Access
- 1 January 2024
- Published by Innovation Press Co., Limited in The Innovation Life
- Vol. 2 (3) , 100088-1-100088-30
Organoids: Principle, application and perspective
Organoid technology, a notable advancement in biomedical engineering, has emerged over the past decade, offering significant scientific and therapeutic potential. By accurately mimicking the structural and functional intricacies of human organs at a small scale, organoids have become a groundbreaking tool for exploring basic biological principles, understanding disease mechanisms, and progressing regenerative medicine. Despite the large number of relevant reports, a comprehensive summary of current organoid research updates is needed urgently for interdisciplinary researchers with an interest in constructing biomimetic tissue models. This review presents a thorough look at the diverse fields of organoid research, covering the fundamental principles guiding organoid formation, the broad applications in various biological systems, and the encouraging prospects they bring for future scientific and clinical pursuits.
- 1 January 2024
- Published by Innovation Press Co., Limited in The Innovation Life
- Vol. 2 (3) , 100088-1-100088-30
Open AccessOrganoids: Principle, application and perspective
Organoid technology, a notable advancement in biomedical engineering, has emerged over the past decade, offering significant scientific and therapeutic potential. By accurately mimicking the structural and functional intricacies of human organs at a small scale, organoids have become a groundbreaking tool for exploring basic biological principles, understanding disease mechanisms, and progressing regenerative medicine. Despite the large number of relevant reports, a comprehensive summary of current organoid research updates is needed urgently for interdisciplinary researchers with an interest in constructing biomimetic tissue models. This review presents a thorough look at the diverse fields of organoid research, covering the fundamental principles guiding organoid formation, the broad applications in various biological systems, and the encouraging prospects they bring for future scientific and clinical pursuits.
- Open Access
- 13 December 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (51)
Nanocolloidal hydrogel mimics the structure and nonlinear mechanical properties of biological fibrous networks
Fibrous networks formed by biological polymers such as collagen or fibrin exhibit nonlinear mechanical behavior. They undergo strong stiffening in response to weak shear and elongational strains, but soften under compressional strain, in striking difference with the response to the deformation of flexible-strand networks formed by molecules. The nonlinear properties of fibrous networks are attributed to the mechanical asymmetry of the constituent filaments, for which a stretching modulus is significantly larger than the bending modulus. Studies of the nonlinear mechanical behavior are generally performed on hydrogels formed by biological polymers, which offers limited control over network architecture. Here, we report an engineered covalently cross-linked nanofibrillar hydrogel derived from cellulose nanocrystals and gelatin. The variation in hydrogel composition provided a broad-range change in its shear modulus. The hydrogel exhibited both shear-stiffening and compression-induced softening, in agreement with the predictions of the affine model. The threshold nonlinear stress and strain were universal for the hydrogels with different compositions, which suggested that nonlinear mechanical properties are general for networks formed by rigid filaments. The experimental results were in agreement with an affine model describing deformation of the network formed by rigid filaments. Our results lend insight into the structural features that govern the nonlinear biomechanics of fibrous networks and provide a platform for future studies of the biological impact of nonlinear mechanical properties.
- 13 December 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (51)
Open AccessNanocolloidal hydrogel mimics the structure and nonlinear mechanical properties of biological fibrous networks
Fibrous networks formed by biological polymers such as collagen or fibrin exhibit nonlinear mechanical behavior. They undergo strong stiffening in response to weak shear and elongational strains, but soften under compressional strain, in striking difference with the response to the deformation of flexible-strand networks formed by molecules. The nonlinear properties of fibrous networks are attributed to the mechanical asymmetry of the constituent filaments, for which a stretching modulus is significantly larger than the bending modulus. Studies of the nonlinear mechanical behavior are generally performed on hydrogels formed by biological polymers, which offers limited control over network architecture. Here, we report an engineered covalently cross-linked nanofibrillar hydrogel derived from cellulose nanocrystals and gelatin. The variation in hydrogel composition provided a broad-range change in its shear modulus. The hydrogel exhibited both shear-stiffening and compression-induced softening, in agreement with the predictions of the affine model. The threshold nonlinear stress and strain were universal for the hydrogels with different compositions, which suggested that nonlinear mechanical properties are general for networks formed by rigid filaments. The experimental results were in agreement with an affine model describing deformation of the network formed by rigid filaments. Our results lend insight into the structural features that govern the nonlinear biomechanics of fibrous networks and provide a platform for future studies of the biological impact of nonlinear mechanical properties.
- 4 November 2023
- Published by Springer Nature
- p. 402-414
A GNSS Spoofing Detection Method Based on CNN-DOA
- 4 November 2023
- Published by Springer Nature
- p. 402-414
A GNSS Spoofing Detection Method Based on CNN-DOA
- Open Access
Printing Structurally Anisotropic Biocompatible Fibrillar Hydrogel for Guided Cell Alignment
Many fibrous biological tissues exhibit structural anisotropy due to the alignment of fibers in the extracellular matrix. To study the impact of such anisotropy on cell proliferation, orientation, and mobility, it is important to recapitulate and achieve control over the structure of man-made hydrogel scaffolds for cell culture. Here, we report a chemically crosslinked fibrous hydrogel due to the reaction between aldehyde-modified cellulose nanofibers and gelatin. We explored two ways to induce structural anisotropy in this gel by extruding the hydrogel precursor through two different printheads. The cellulose nanofibers in the hydrogel ink underwent shear-induced alignment during extrusion and retained it in the chemically crosslinked hydrogel. The degree of anisotropy was controlled by the ink composition and extrusion flow rate. The structural anisotropy of the hydrogel extruded through a nozzle affected the orientation of human dermal fibroblasts that were either seeded on the hydrogel surface or encapsulated in the extruded hydrogel. The reported straightforward approach to constructing fibrillar hydrogel scaffolds with structural anisotropy can be used in studies of the biological impact of tissue anisotropy.
Open AccessPrinting Structurally Anisotropic Biocompatible Fibrillar Hydrogel for Guided Cell Alignment
Many fibrous biological tissues exhibit structural anisotropy due to the alignment of fibers in the extracellular matrix. To study the impact of such anisotropy on cell proliferation, orientation, and mobility, it is important to recapitulate and achieve control over the structure of man-made hydrogel scaffolds for cell culture. Here, we report a chemically crosslinked fibrous hydrogel due to the reaction between aldehyde-modified cellulose nanofibers and gelatin. We explored two ways to induce structural anisotropy in this gel by extruding the hydrogel precursor through two different printheads. The cellulose nanofibers in the hydrogel ink underwent shear-induced alignment during extrusion and retained it in the chemically crosslinked hydrogel. The degree of anisotropy was controlled by the ink composition and extrusion flow rate. The structural anisotropy of the hydrogel extruded through a nozzle affected the orientation of human dermal fibroblasts that were either seeded on the hydrogel surface or encapsulated in the extruded hydrogel. The reported straightforward approach to constructing fibrillar hydrogel scaffolds with structural anisotropy can be used in studies of the biological impact of tissue anisotropy.
- Open Access
- 27 May 2022
- Published by Taylor & Francis in Journal of Applied Animal Research
- Vol. 50 (1) , 342-349
Wanxi White goose and Yangzhou goose exhibited differences in the level of egg production, serum biochemical, hormones and related gene expression under the same natural photoperiod regulation
Egg production is seasonally regulated by the photoperiod in geese. To evaluate the effect of the natural photoperiod on egg production, 30 males and 120 females of 270-day-old Wanxi white geese and Yangzhou geese were selected and divided into two groups according to the breed. Both groups were raised under the natural photoperiod. Compared with the Yangzhou goose, the Wanxi white goose had a lower laying rate and higher expression levels of follicle-stimulating hormone receptor and anti-Müllerian hormone receptor 2 (AMHR2) in the ovary at the peak-laying period. Compared with the early-laying period, both breeds had lower serum uric acid and triacylglycerol levels, and higher serum cholesterol and high-density lipoprotein cholesterol levels at the peak-laying period. The level of the serum luteinizing hormone (LH) at the pre-laying period was higher than that of the other egg-laying periods in the Yangzhou goose. In conclusion, the photoperiod affected egg production in geese, which was accompanied by changes in serum biochemical parameters and serum reproductive hormone levels. The concentration of the serum LH might be associated with the maturation of ovary and oviducts. In the Wanxi white goose, higher expression of AMHR2 might cause a lower sensitivity of follicles to the level of the FSH.
- 27 May 2022
- Published by Taylor & Francis in Journal of Applied Animal Research
- Vol. 50 (1) , 342-349
Open AccessWanxi White goose and Yangzhou goose exhibited differences in the level of egg production, serum biochemical, hormones and related gene expression under the same natural photoperiod regulation
Egg production is seasonally regulated by the photoperiod in geese. To evaluate the effect of the natural photoperiod on egg production, 30 males and 120 females of 270-day-old Wanxi white geese and Yangzhou geese were selected and divided into two groups according to the breed. Both groups were raised under the natural photoperiod. Compared with the Yangzhou goose, the Wanxi white goose had a lower laying rate and higher expression levels of follicle-stimulating hormone receptor and anti-Müllerian hormone receptor 2 (AMHR2) in the ovary at the peak-laying period. Compared with the early-laying period, both breeds had lower serum uric acid and triacylglycerol levels, and higher serum cholesterol and high-density lipoprotein cholesterol levels at the peak-laying period. The level of the serum luteinizing hormone (LH) at the pre-laying period was higher than that of the other egg-laying periods in the Yangzhou goose. In conclusion, the photoperiod affected egg production in geese, which was accompanied by changes in serum biochemical parameters and serum reproductive hormone levels. The concentration of the serum LH might be associated with the maturation of ovary and oviducts. In the Wanxi white goose, higher expression of AMHR2 might cause a lower sensitivity of follicles to the level of the FSH.
- Open Access
- 1 January 2022
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (2) , 891-909
Emerging microfluidics-enabled platforms for osteoarthritis management: from benchtop to bedside
Osteoarthritis (OA) is a prevalent debilitating age-related joint degenerative disease. It is a leading cause of pain and functional disability in older adults. Unfortunately, there is no cure for OA once the damage is established. Therefore, it promotes an urgent need for early detection and intervention of OA. Theranostics, combining therapy and diagnosis, emerges as a promising approach for OA management. However, OA theranostics is still in its infancy. Three fundamental needs have to be firstly fulfilled: i) a reliable OA model for disease pathogenesis investigation and drug screening, ii) an effective and precise diagnostic platform, and iii) an advanced fabrication approach for drug delivery and therapy. Meanwhile, microfluidics emerges as a versatile technology to address each of the needs and eventually boost the development of OA theranostics. Therefore, this review focuses on the applications of microfluidics, from benchtop to bedside, for OA modelling and drug screening, early diagnosis, and clinical therapy. We first introduce the basic pathophysiology of OA and point out the major unfilled research gaps in current OA management including lack of disease modelling and drug screening platforms, early diagnostic modalities and disease-modifying drugs and delivery approaches. Accordingly, we then summarize the state-of-the-art microfluidics technology for OA management from in vitro modelling and diagnosis to therapy. Given the existing promising results, we further discuss the future development of microfluidic platforms towards clinical translation at the crossroad of engineering and biomedicine.
- 1 January 2022
- Published by Ivyspring International Publisher in Theranostics
- Vol. 12 (2) , 891-909
Open AccessEmerging microfluidics-enabled platforms for osteoarthritis management: from benchtop to bedside
Osteoarthritis (OA) is a prevalent debilitating age-related joint degenerative disease. It is a leading cause of pain and functional disability in older adults. Unfortunately, there is no cure for OA once the damage is established. Therefore, it promotes an urgent need for early detection and intervention of OA. Theranostics, combining therapy and diagnosis, emerges as a promising approach for OA management. However, OA theranostics is still in its infancy. Three fundamental needs have to be firstly fulfilled: i) a reliable OA model for disease pathogenesis investigation and drug screening, ii) an effective and precise diagnostic platform, and iii) an advanced fabrication approach for drug delivery and therapy. Meanwhile, microfluidics emerges as a versatile technology to address each of the needs and eventually boost the development of OA theranostics. Therefore, this review focuses on the applications of microfluidics, from benchtop to bedside, for OA modelling and drug screening, early diagnosis, and clinical therapy. We first introduce the basic pathophysiology of OA and point out the major unfilled research gaps in current OA management including lack of disease modelling and drug screening platforms, early diagnostic modalities and disease-modifying drugs and delivery approaches. Accordingly, we then summarize the state-of-the-art microfluidics technology for OA management from in vitro modelling and diagnosis to therapy. Given the existing promising results, we further discuss the future development of microfluidic platforms towards clinical translation at the crossroad of engineering and biomedicine.